Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.0600-0.1700 (-7.62%)
At close: 04:00PM EST
2.0800 +0.02 (+0.97%)
After hours: 07:42PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.2300
Open2.1400
Bid2.0800 x 800
Ask2.1500 x 1800
Day's Range2.0600 - 2.1800
52 Week Range1.3500 - 126.2600
Volume207,848
Avg. Volume1,580,544
Market Cap27.867M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Shuttle Pharmaceuticals to Present at Lytham Partners Investor Select Conference on January 31

    Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced Anatoly Dritschilo, M.D., CEO, will present and host one-on-one meetings with investors at the Lytham Partners Investor Select Conference, taking place virtually on January 31, 2023.

  • PR Newswire

    Shuttle Pharmaceuticals to Ring Nasdaq Opening Bell on Wednesday, January 18, 2023

    Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced that Chairman and Chief Executive Officer, Anatoly Dritschilo, M.D., CEO, and other Shuttle Pharmaceuticals team members will ring the Nasdaq opening bell on Wednesday, January 18, 2023.

  • PR Newswire

    Shuttle Pharmaceuticals Announces Private Placement of $4.3 Million of Senior Secured Convertible Note and Warrants

    Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while reducing side effects, announced the issuance of a $4.3 million senior secured convertible note and warrant to an institutional investor. Shuttle Pharmaceuticals will receive initial gross proceeds of $4.0 million. In addition, the four-year warrant to purchase up to approximately 1

Advertisement
Advertisement